Hepion Pharmaceuticals
HEPA0.071655.99% ( +0.0257 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Hepion Pharmaceuticals(HEPA) the EBIT is -798.51 K (+37.65%);the EPS is -0.0698 (+96.76%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B37.65%
----
----
EPS
-0.069896.76%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf